Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
‘Intervene & restore normalcy’: Bengal BJP writes to guv amid violence
Amidst escalating violence in West Bengal following anti-Waqf law protests, BJP chief Sukanta Majumdar has appealed to Governor CV Ananda Bose for intervention. Majumdar expressed […]
‘Gukesh accepted he didn’t do well’
D Gukesh, the world chess champion, struggled in the 2025 Freestyle Chess Grand Slam Tour’s opening leg but remains optimistic for the Paris leg. Despite […]
RBI warns investors against these videos circulating online
The Reserve Bank of India issued a warning to the public regarding deepfake videos circulating online. These videos, featuring fabricated footage of RBI Governor Shaktikanta […]